Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Integrated Database Helps Detect Biomarkers to Neurological Diseases

By LabMedica International staff writers
Posted on 20 May 2009
A searchable, integrated database of human genes provides concise genomic, proteomic, transcriptomic, genetic, and functional information on all known and predicted human genes. More...
It will be used to identify and characterize protein biomarkers for serious neurological diseases.

Information featured in the database, which is called GeneCards, includes orthologies, disease relationships, mutations and single nucleotide polymorphisms (SNPs), gene expression, gene function, pathways, protein-protein interactions, related drugs and compounds, and direct links to research reagents and tools such as antibodies, recombinant proteins, clones, expression assays and RNAi reagents.

GeneCards was developed by a bioinformatics team at the Weizmann Institute of Science (Rehovot, Israel) directed by Marilyn Safran and Prof. Doron Lancet of the department of molecular genetics, and head of the Crown Human Genome Center.

Xennex (Cambridge MA, USA) has provided Satoris (Redwood City, CA, USA) with access to GeneCards and associated tools. Satoris is utilizing GeneCards and the related technology for investigations related to its identification and characterization of protein biomarkers associated with neurological disease such as Alzheimer's, Parkinson's, multiple sclerosis, and diabetic neuropathy, to create new diagnostic tools for earlier, better healthcare decisions.

The newly released GeneCards Version 3.0 features a significantly upgraded infrastructure, including a comprehensive relational biological database, and a sophisticated, and speedier search engine. It provides capabilities for effective and well-targeted queries, a user-friendly display, and clear data navigation. Also released, a preliminary version of GeneDecks Version 3, which makes use of the new GeneCards relational database for complex analyses on sets of genes.

Dr. David Warshawsky, president & CEO of Xennex, stated: "We are very pleased that we can offer Satoris our most advanced tools and the latest GeneCards developments to assist in their work. Satoris' work is of great potential for improved diagnosis and treatment of devastating conditions."

Related Links:

GeneCards
Weizmann Institute of Science
Xennex
Satoris



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.